COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 2344: Articles 23431-23440  | Next

Data-Driven Development of a Small-Area COVID-19 Vulnerability Index for the United States
amram, o., Amiri, S., Thorn, E. L., Mansfield, J. J., Mellacheruvu, P., Monsivais, P.
10.1101/2020.08.17.20176248 — Posted: 2020-08-18
Healthcare workers high COVID-19 infection rate: the source of infections and potential for respirators and surgical masks to reduce occupational infections
Oksanen, L.-M. A. H., Sanmark, E., Oksanen, S., Anttila, V.-J., Paterno, J. J., Lappalainen, M., Lehtonen, L., Geneid, A.
10.1101/2020.08.17.20176842 — Posted: 2020-08-18 Discussion: Onsite
Evidence and magnitude of seasonality in SARS-CoV-2 transmission: Penny wise, pandemic foolish?
Kaplin, A. I., Junker, C., Kumar, A., de Amorim Ribeiro, M. A., Yu, E., Wang, M., Smith, T., Rai, S. N., Bhatnager, A.
10.1101/2020.08.17.20176610 — Posted: 2020-08-18
Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 14th and 28th day of the disease course: a retrospective cohort study in Bangladesh
Islam, M. Z., Riaz, B. K., Islam, A. S., Khanam, F., Akhter, J., Choudhury, R., Farhana, N., Uddin, M. J., Efa, S. S.
10.1101/2020.08.17.20176586 — Posted: 2020-08-18
Transcriptomic profiling of human corona virus (HCoV)-229E -infected human cells and genomic mutational analysis of HCoV-229E and SARS-CoV-2
Friedman, N., Jacob-Hirsch, J., Drori, Y., Eyal, E., Kol, N., Nayshool, O., Mendelson, E., Rechavi, G., Mandelboim, M.
10.1101/2020.08.17.253682 — Posted: 2020-08-17
SARS-Cov-2-, HIV-1-, Ebola-neutralizing and anti-PD1 clones are predisposed
Zhang, Y., Xu, Q., Zeng, H., Wang, M., Zhang, Y., Lan, C., Yang, X., Zhu, Y., Chen, Y., Wang, Q., Tang, H., Zhang, Y., Wu, J., Wang, C., Xie, W., Ma, C., Guan, J., Guo, S., Chen, S., Chang, C., Yang, W., Wei, L., Ren, J., Yu, X., Zhang, Z.
10.1101/2020.08.13.249086 — Posted: 2020-08-17
A lesson from COVID-19 on inaccessibility of web-based information for disabled populations worldwide
Dror, A. A., Layous, E., Mizrachi, M., Daoud, A., Eisenbach, N., Morozov, N. G., Srouji, S., Avraham, K. B., Sela, E.
10.1101/2020.08.16.252676 — Posted: 2020-08-17
SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways
Han, L., Zhuang, M.-W., Zheng, Y., Zhang, J., Nan, M.-L., Wang, P.-H., Gao, C.
10.1101/2020.08.16.252973 — Posted: 2020-08-17
COVID-19 among nursing staff: Settings and regional differences
Hoedl, M., Eglseer, D., Bauer, S.
10.1101/2020.08.14.20174797 — Posted: 2020-08-17
A data-driven epidemiological model to explain the Covid-19 pandemic in multiple countries and help in choosing mitigation strategies
Beira, M. J., Kumar, A., Perfeito, L., Goncalves-Sa, J., Sebastiao, P. J.
10.1101/2020.08.15.20175588 — Posted: 2020-08-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).